Jinghua Pharmaceutical Group Co Ltd banner

Jinghua Pharmaceutical Group Co Ltd
SZSE:002349

Watchlist Manager
Jinghua Pharmaceutical Group Co Ltd Logo
Jinghua Pharmaceutical Group Co Ltd
SZSE:002349
Watchlist
Price: 7.72 CNY -1.28% Market Closed
Market Cap: ¥6.3B

Jinghua Pharmaceutical Group Co Ltd
Investor Relations

Jinghua Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing. The company is headquartered in Nantong, Jiangsu and currently employs 2,065 full-time employees. The company went IPO on 2010-02-03. The firm is also engaged in the provision of traditional Chinese medicinal materials and Chinese herbal pieces, among others. The firm primarily provides tablets, capsules, pills, granules, injections, powder, syrup, healthcare products, beverages and chemical intermediates, among others. The firm offers Chinese patent medicines, such as Wangshi Baochiwan pills and Jidesheng tablets. Its bulk drugs include phenobarbitone and fluorouracil. The firm distributes its products in domestic and overseas markets.

Show more
Loading
002349
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yunzhong Zhou
GM & Vice Chairman
No Bio Available
Mr. Yuxiang Wu
Executive VP, CFO & Director
No Bio Available
Mr. Jianfeng Wang
Board Secretary
No Bio Available

Contacts

Address
JIANGSU
Nantong
21-25F, Building A, Guocheng Shenghuo Plaza, No. 198 Qingnian Middle Road, Chongchuan District
Contacts
+8651385609123
www.ntjhzy.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett